Skip to main content
. 2022 Oct 10;10(12):1160–1168. doi: 10.1016/S2213-2600(22)00299-5

Table 2.

Colchicine versus control—outcomes*

Colchicine group (n=1939) Control group (n=1942) Hazard ratio (95% CI) p value
Hospitalisation or death 66 (3·4%) 65 (3·3%) 1·02 (0·72–1·43) 0·93
Hospitalisation or respiratory death 65 (3·4%) 65 (3·3%) 1·00 (0·71–1·41) 0·99
Hospitalisation 62 (3·2%) 61 (3·1%) 1·02 (0·71–1·45) 0·92
Death 12 (0·6%) 11 (0·6%) 1·09 (0·48–2·47) 0·84
Respiratory death 10 (0·5%) 7 (0·4%) 1·43 (0·54–3·75) 0·47

Data are n (%) unless stated otherwise.

*

Any thrombosis occurred in three patients randomly assigned to colchicine and four randomly assigned to control. Pulmonary embolism occurred in one patient randomly assigned to colchicine and two randomly assigned to control.

Primary outcome.